BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robak E, Jesionek-Kupnicka D, Robak T. Skin changes in hairy cell leukemia. Ann Hematol 2021;100:615-25. [PMID: 33216198 DOI: 10.1007/s00277-020-04349-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Puła A, Robak T. Hairy cell leukemia: a brief update on current knowledge and treatment prospects. Curr Opin Oncol 2021;33:412-9. [PMID: 34264896 DOI: 10.1097/CCO.0000000000000771] [Reference Citation Analysis]
2 Robak E, Jesionek-Kupnicka D, Iskierka-Jazdzewska E, Janus A, Robak T. Cutaneous leukocytoclastic vasculitis at diagnosis of hairy cell leukemia successfully treated with vemurafenib and rituximab. Leuk Res 2021;104:106571. [PMID: 33831657 DOI: 10.1016/j.leukres.2021.106571] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kreitman RJ, Arons E. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues. Blood Rev 2021;:100888. [PMID: 34535326 DOI: 10.1016/j.blre.2021.100888] [Reference Citation Analysis]